• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Response evaluation criteria in solid tumours (RECIST): problems and need for modifications in paediatric oncology?

作者信息

McHugh K, Kao S

机构信息

Radiology Department, Great Ormond Street Hospital For Children, London WC1N 3JH, UK.

出版信息

Br J Radiol. 2003 Jul;76(907):433-6. doi: 10.1259/bjr/15521966.

DOI:10.1259/bjr/15521966
PMID:12857700
Abstract
摘要

相似文献

1
Response evaluation criteria in solid tumours (RECIST): problems and need for modifications in paediatric oncology?实体瘤疗效评价标准（RECIST）：儿科肿瘤学中存在的问题及修改的必要性？
Br J Radiol. 2003 Jul;76(907):433-6. doi: 10.1259/bjr/15521966.
2
Can paediatric radiologists resist RECIST (response evaluation criteria in solid tumours)?儿科放射科医生能否抵制实体瘤疗效评价标准（RECIST）？
Pediatr Radiol. 2003 Nov;33(11):739-43. doi: 10.1007/s00247-003-1067-6.
3
Response evaluation criteria in solid tumors (RECIST): new guidelines.实体瘤疗效评价标准（RECIST）：新指南
Med Pediatr Oncol. 2001 Jul;37(1):1-3. doi: 10.1002/mpo.1154.
4
Advances in paediatric tumour imaging.儿科肿瘤成像的进展。
Arch Dis Child. 2005 Jun;90(6):608-11. doi: 10.1136/adc.2004.051193.
5
RECIST 1.1-Update and clarification: From the RECIST committee.RECIST 1.1更新与说明：来自RECIST委员会。
Eur J Cancer. 2016 Jul;62:132-7. doi: 10.1016/j.ejca.2016.03.081. Epub 2016 May 14.
6
Limitations with the response evaluation criteria in solid tumors (RECIST) guidance in disseminated pediatric malignancy.实体瘤疗效评价标准（RECIST）指南在儿童播散性恶性肿瘤中的局限性。
Pediatr Blood Cancer. 2006 Feb;46(2):127-34. doi: 10.1002/pbc.20344.
7
RECIST 1.1 - Standardisation and disease-specific adaptations: Perspectives from the RECIST Working Group.RECIST 1.1 - 标准化与疾病特异性调整：RECIST 工作组的观点
Eur J Cancer. 2016 Jul;62:138-45. doi: 10.1016/j.ejca.2016.03.082. Epub 2016 May 26.
8
Response assessment in solid tumours: a comparison of WHO, SWOG and RECIST guidelines.实体瘤的疗效评估：WHO、SWOG与RECIST指南的比较
Br J Radiol. 2008 Jun;81(966):444-9. doi: 10.1259/bjr/32785946. Epub 2008 Mar 3.
9
Tumor response evaluation in oncology: current update.肿瘤学中的肿瘤反应评估：当前进展
J Comput Assist Tomogr. 2010 Jul;34(4):479-84. doi: 10.1097/RCT.0b013e3181db2670.
10
Radiologic measurements of tumor response to treatment: practical approaches and limitations.肿瘤治疗反应的放射学测量：实用方法与局限性
Radiographics. 2008 Mar-Apr;28(2):329-44. doi: 10.1148/rg.282075068.

引用本文的文献

1
Adaptive individualized gene pair signatures distinguishing melanoma and predicting response to immune checkpoint blockade.区分黑色素瘤并预测免疫检查点阻断反应的适应性个体化基因对特征
iScience. 2025 Aug 8;28(9):113329. doi: 10.1016/j.isci.2025.113329. eCollection 2025 Sep 19.
2
Outcome of Patients With Malignant Peripheral Nerve Sheath Tumors Enrolled on Sarcoma Alliance for Research Through Collaboration (SARC) Phase II Trials.协作型肉瘤研究联盟（SARC）二期临床试验入组的恶性外周神经鞘瘤患者的结局。
Oncologist. 2023 May 8;28(5):453-459. doi: 10.1093/oncolo/oyac272.
3
Recent and Ongoing Research into Metastatic Osteosarcoma Treatments.
转移性骨肉瘤治疗的最新和正在进行的研究。
Int J Mol Sci. 2022 Mar 30;23(7):3817. doi: 10.3390/ijms23073817.
4
Successive Osteosarcoma Relapses after the First Line O2006/Sarcome-09 Trial: What Can We Learn for Further Phase-II Trials?一线O2006/Sarcome-09试验后骨肉瘤的连续复发：对于进一步的II期试验我们能学到什么？
Cancers (Basel). 2021 Apr 2;13(7):1683. doi: 10.3390/cancers13071683.
5
Predictive values of serum VEGF and CRP levels combined with contrast enhanced MRI in hepatocellular carcinoma patients after TACE.血清VEGF和CRP水平联合对比增强MRI对TACE术后肝癌患者的预测价值
Am J Cancer Res. 2016 Oct 1;6(10):2375-2385. eCollection 2016.
6
Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move Forward.通过儿童癌症研究组、儿科肿瘤学组和儿童肿瘤学组参与七项II期试验的复发性骨肉瘤患者的治疗结果：借鉴过去，展望未来。
J Clin Oncol. 2016 Sep 1;34(25):3031-8. doi: 10.1200/JCO.2015.65.5381. Epub 2016 Jul 11.
7
Intravenous ultrasound contrast agents versus other imaging methods in pediatric patients with neoplastic diseases - a comparison.静脉注射超声造影剂与其他成像方法在小儿肿瘤性疾病中的比较
J Ultrason. 2013 Dec;13(55):438-45. doi: 10.15557/JoU.2013.0047. Epub 2013 Dec 30.
8
A new metric for detecting change in slowly evolving brain tumors: validation in meningioma patients.一种用于检测缓慢演变脑肿瘤变化的新指标：在脑膜瘤患者中的验证。
Neurosurgery. 2011 Mar;68(1 Suppl Operative):225-33. doi: 10.1227/NEU.0b013e31820783d5.
9
Cisplatin pharmacokinetics in a child receiving peritoneal dialysis.顺铂在接受腹膜透析的儿童中的药代动力学。
Pediatr Nephrol. 2010 Jun;25(6):1185-9. doi: 10.1007/s00467-009-1420-6. Epub 2010 Jan 19.
10
RECIST revised: implications for the radiologist. A review article on the modified RECIST guideline.RECIST 修订版：对放射科医生的影响。一篇关于修改后的 RECIST 指南的综述文章。
Eur Radiol. 2010 Jun;20(6):1456-67. doi: 10.1007/s00330-009-1685-y. Epub 2009 Dec 22.